Medical Office Building vs. MedTail in 2026: Which Net Lease Medical Asset Delivers Better Risk-Adjusted Returns

Medical net lease is not a monolithic asset class, and conflating MOBs with MedTail is one of the most expensive mistakes an NNN investor can make in 2026. The two formats carry different cap rate profiles, different tenant credit structures, different re-leasing risk, and different exposure to the macro tailwinds reshaping healthcare delivery. Understanding which one belongs in your portfolio requires a clear-eyed look at both, starting with what each format actually is.

Defining the Asset Classes

Medical Office Building (MOB): A purpose-built, multi- or single-tenant property designed specifically for outpatient clinical use, including physician groups, surgical suites, imaging centers, and specialty practices. MOBs are typically configured with clinical infrastructure: reinforced flooring, upgraded HVAC, heavy electrical, plumbing for procedure rooms, and specialized buildout at $80-$200 per square foot.

MedTail: A healthcare service delivered in a retail real estate format. Strip center, inline retail, or freestanding pad site in a retail corridor. MedTail refers to healthcare services delivered in a retail environment, often in shopping centers or strip malls. Urgent care clinics, dialysis centers, dental practices, physical therapy, and behavioral health are the most common occupants. The format prioritizes patient accessibility, visibility, and co-tenancy with everyday retail.

These two assets share the same underlying demand driver, a growing, aging patient population seeking outpatient care, but they are priced differently, financed differently, and underwritten differently.

The Macro Case: Why Both Assets Are Well-Positioned

The structural argument for medical net lease in 2026 is unusually strong. According to CMS, NHE grew 7.2% to $5.3 trillion in 2024, accounting for 18.0% of GDP. Up from 17.6% of GDP in 2023, confirming that health spending's share of the economy is expanding. Over 2024-2033, average NHE growth of 5.8% is projected to outpace GDP growth of 4.3%, resulting in an increase in the health spending share of GDP from 17.6% in 2023 to 20.3% in 2033. That trajectory creates durable demand for the physical real estate where care is delivered.

Healthcare real estate is positioned to outperform broader commercial real estate in 2026. For context on the benchmark: the PREA consensus forecasts NPI blended returns of approximately 6.8% per annum over 2026-2030, according to Capital Economics, while healthcare real estate benefits from demographic tailwinds, sustained outpatient demand, and its role as a core defensive asset that is structurally less sensitive to cyclical swings in the broader economy. Tight market conditions and limited new construction will continue into 2026, maintaining upward pressure on rents and reinforcing stable fundamentals.

Healthcare real estate is anchored by strong fundamentals that help it withstand broader market slowdowns. According to PwC's Emerging Trends in Real Estate 2026 edition, MOB occupancy reached a cyclical high of 92.7% across the top 100 metro areas as of 2Q 2025, driven by absorption consistently outpacing new deliveries, and performance anchored by the predictability of physician and healthcare group tenancy.

Both MOBs and MedTail benefit from this environment. But the split in how each format captures that demand, and at what risk, is where the analysis gets consequential.

Cap Rate Landscape: Where MOBs and MedTail Are Pricing in 2026

Medical Office Buildings

Medical office building cap rates in Q1 2026 range from 5.5% to 8.5%, with significant variation based on property quality, location, tenant profile, and lease terms. The national average for institutional-quality properties stands at approximately 6.3%, representing 25-50 basis point compression from 2023-2024 levels as interest rates stabilized and investor demand strengthened.

Tenant type drives the widest spread within the MOB category. Hospital system tenants with investment-grade health systems under long-term NNN leases trade at 6.0-6.5%, while large physician groups with 10+ year operating histories trade at 6.5-7.2%, and small practices face cap rates of 7.0-7.8% due to tenant concentration risk. Lease term also matters acutely: buildings with remaining terms under 3 years typically trade 100-150 basis points higher than comparable properties with 10+ year terms.

MedTail by Tenant Category

MedTail cap rates are not uniform; they are tenant-driven. The spread between the best and weakest credit operators in the sector can exceed 200 basis points on identical real estate.

  • Dialysis (Fresenius / DaVita): Dialysis centers trade at 6.5-7.0%, supported by stable, recession-resistant cash flows and their essential service nature, according to CREG Healthcare's Q1 2026 market analysis. According to Wikipedia, citing the company's public profile, Fresenius Medical Care holds approximately a 38% share of the U.S. dialysis market, operating a global network of over 4,100 outpatient dialysis centers. Note that market share figures in this duopoly are tracked differently across sources: according to GlobalData / GM Insights, DaVita led the U.S. dialysis market with over 38% share in 2024, with the top five players collectively holding approximately 70% of the market. Investors should treat both operators as sharing roughly equal dominant positions, together accounting for the substantial majority of U.S. dialysis clinic volume. Brand-new, long-term leases in top markets can compress into the mid-5% to low-6% range, while older or shorter-term leases trend toward the upper end of the range or higher, according to investmentgrade.com's March 2026 healthcare NNN analysis.
  • Investment-Grade Urgent Care (MedExpress/Optum): MedExpress NNN properties trade in the 5.50% to 6.75% cap rate range as of Q1 2026, reflecting the strong UnitedHealth Group parent credit.
  • Franchise Urgent Care (AFC, similar operators): AFC Urgent Care NNN properties trade in the 7.00% to 8.50% cap rate range as of Q1 2026, reflecting the franchisee guarantee structure. Strong multi-unit franchisees may trade toward 7.00%, while single-unit operators price closer to 8.50%.
  • Imaging Centers: Trade at 7.0-7.5%, with equipment obsolescence risk and competition from hospital outpatient departments requiring higher returns.

The single-tenant net lease market overall was pricing at a 6.80% blended cap rate in Q1 2026. Single-tenant net lease cap rates decreased by one basis point to 6.80%, while retail cap rates remained unchanged at 6.55% in Q1 2026, according to The Boulder Group.

Risk-Adjusted Return Framework: The Four Variables That Matter

A headline cap rate comparison between MOBs and MedTail is insufficient underwriting. Four variables determine which format delivers superior risk-adjusted returns on any specific deal.

1. Tenant Credit Quality

This is the primary driver of value in both formats. A 6.5% cap rate in medical office is not the same risk as a 6.5% cap in an older strip retail center with month-to-month tenants. In the MOB space, credit is assessed at the practice or health system level. In MedTail, credit analysis must account for whether the guarantee is corporate (investment-grade parent), franchisee (private, unrated), or entity-level only.

Medical services tenants - dental, dialysis, veterinary, and behavioral health - carry NNN investment appeal due to their non-cyclical demand, sticky tenancy, and favorable renewal probabilities relative to general retail alternatives.

2. Lease Structure and Tenant Stickiness

Both formats benefit from long-term occupancy due to high buildout costs. Medical office tenancy is typically structured at 7-10 years per initial term, according to multiple industry sources including Colliers and the Medical Construction Group, with leases for specialty practices such as surgery centers, imaging, and dialysis trending toward the longer end of that range due to the depth and specificity of their buildouts. The cited upper bound of 15 years is atypical for standard physician group leases; it is more representative of hospital-affiliated or large institutional NNN sale-leaseback structures. Renewal probability is high across the sector: with medical buildout costs running $80-$200 per square foot, relocation is painful enough that most tenants renew rather than move, particularly when the practice owns the patient base at that location. No industry-wide renewal rate is uniformly reported, but the economics of medical buildout create structural stickiness that far exceeds general retail.

MedTail tenants are similarly sticky. Once established, medtail tenants are less likely to relocate due to the cost of moving specialized equipment and the importance of maintaining their patient base in a specific location.

3. Re-Leasing and Alternative Use Risk

This is where MOBs carry meaningful long-term risk that MedTail largely avoids. A single-tenant MOB leased to a small physician group in a secondary market faces a highly illiquid re-leasing pool if the tenant vacates. Clinical infrastructure is expensive to remove and hard to retrofit for non-medical use. MedTail properties, particularly freestanding pad sites and inline retail space in high-traffic corridors, have broader alternative use value. The real estate itself can re-tenant to non-medical users, which provides a meaningful exit backstop.

4. Rent Escalations and NOI Growth

Most medical leases include annual rent escalations of 2-3% annually or CPI adjustments, providing natural inflation hedging. This applies to both formats. However, MedTail properties in high-demand retail corridors have demonstrated the ability to re-price at lease rollover above in-place escalation rates, supported by the structural tightness of the retail supply environment. According to CoStar, average U.S. retail rents hit a record $25.69 per square foot in 2025, and retail construction starts fell to historic lows, with developers starting less than 43 million square feet - the lowest on record. In high-growth Sunbelt markets, where medical providers are actively competing for a shrinking pool of quality retail real estate, rollover rent resets have outpaced contractual escalations where lease marks-to-market have occurred. This dynamic is most visible in markets with sub-4% retail vacancy rates and meaningful population growth, where MedTail operators face limited relocation alternatives at rollover.

Where Each Asset Type Wins

MOBs Win When:

  • The tenant is an investment-grade health system or large multi-specialty group with 10+ year remaining term
  • The property is on-campus or adjacent to a hospital, creating institutional credit quality and deep buyer demand at exit
  • The investor prioritizes bond-like income stability over yield optimization
  • The deal structure is a sale-leaseback with a creditworthy practice group, creating a long-term NNN lease from scratch

MedTail Wins When:

  • The tenant carries investment-grade corporate guarantees (Optum/UnitedHealth, Fresenius, DaVita)
  • The property is located in a high-traffic retail corridor with strong alternative use value
  • The price point is below $5M, fitting the 1031 exchange buyer profile who needs liquidity and a broad resale market
  • The investor wants more yield than on-campus MOBs provide, without moving fully into non-investment-grade credit territory

The 1031 Exchange Consideration

For 1031 exchange buyers operating under a 45-day identification window, both formats are viable but not equally accessible. MedTail, particularly single-tenant, net-leased urgent care and dialysis properties in the $2M-$6M range, represents a significantly larger inventory pool than on-campus, investment-grade MOBs, which are dominated by institutional portfolios and rarely trade as single-asset sales at accessible price points.

In the 1031 context, the non-cyclical demand profile of medical services tenants translates directly into underwriting confidence: net lease buyers working against identification deadlines have less tolerance for credit uncertainty, and the corporate-guaranteed MedTail tenant roster gives them a viable path to closing without sacrificing lease structure. According to Northmarq, 1031 exchange buyers have historically been a major factor keeping demand strong for core net lease assets - though their activity has been largely anecdotal to quantify precisely, and their influence on cap rates waxes and wanes with broader transaction volume. Retail properties account for approximately 31% of 1031 exchanges by transaction count, according to investmentgrade.com, making single-tenant NNN medical retail a natural fit for exchange capital seeking passive, credit-backed income.

Frequently Asked Questions

What is the difference between a Medical Office Building (MOB) and MedTail?

A Medical Office Building is a purpose-built clinical facility designed for outpatient medical use, often on or near a hospital campus. MedTail is healthcare delivered in a retail real estate format: inline strip center space, freestanding pads, or shopping center suites, prioritizing patient convenience and visibility. Both can be structured as NNN leases, but they carry different credit profiles, re-leasing dynamics, and cap rate ranges.

What cap rates are MOBs and MedTail properties trading at in 2026?

Institutional-quality MOBs with investment-grade health system tenants are trading at 6.0-6.5% in 2026. Smaller physician group-leased MOBs price at 6.5-7.8% depending on practice size and remaining term. MedTail cap rates range from 5.5%-6.75% for investment-grade operators like MedExpress/Optum, to 6.5-7.0% for dialysis operators like Fresenius and DaVita, to 7.0%-8.5% for franchisee-guaranteed urgent care operators.

Which medical NNN asset is better for a 1031 exchange buyer?

MedTail typically offers a wider inventory of available single-tenant deals in the $1.5M-$6M range, making it more accessible for 1031 exchange buyers with identification deadlines. Investment-grade MOBs in this price range are rare; most quality on-campus assets trade in larger portfolio transactions. Both formats can work for 1031 buyers, but deal availability strongly favors MedTail.

How does tenant credit affect the value of a MedTail property?

Tenant credit is the dominant pricing variable in MedTail. A 200+ basis point cap rate spread exists between investment-grade corporate-guaranteed MedTail (Optum, Fresenius) and franchisee-guaranteed operators with no public credit ratings. Buyers should always verify the specific guarantee structure on each NNN lease. Entity-level guarantees from an unrated franchisee carry materially different risk than a parent corporate guarantee from an A-rated health system.

What are the biggest risks to watch in medical net lease in 2026?

For MOBs, the primary risks are tenant concentration in small practice groups, high re-leasing costs if the tenant vacates, and illiquidity of purpose-built clinical space in secondary markets. For MedTail, the risks center on non-investment-grade franchise credits, payer reimbursement changes affecting operator revenue, and Medicaid enrollment shifts tied to current federal policy changes. In both formats, lease term remaining and the strength of the guarantee are the most consequential factors in underwriting.

Kentwood Capital specializes in single-tenant NNN lease retail and medical real estate acquisitions, dispositions, and 1031 exchange advisory. If you are evaluating a MedTail or MOB acquisition, contact our team for deal-level underwriting support and current market comps.